B

BioArctic
BIOA B

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
SEK25.19B
EV
SEK23.32B
Shares Outstanding
88.64M
Beta
-0.92
Industry
Biotechnology

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
Number of Analysts
5
P/E 2025E
25.02x
P/Revenue 2025E
12.98x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About BioArctic AB (publ)

gainify

B

BioArctic AB (publ)

BIOA B

BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of innovative biological drugs, such as antibodies that address high unmet medical needs. The company’s therapeutic a...

Sector

Healthcare

Industry

Biotechnology

CEO

Osswald, Gunilla

Employees

119

IPO Date

2017-10-12

Headquarters

Warfvinges vag 35, Stockholm, Stockholm County, 112 51, Sweden

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.